ZIM Corporation (ZIMCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 17, 2026
ZIM Corporation Company Description
ZIM Corporation operates in the biomedical and emerging technology companies.
It focuses on developing intellectual property, and research and development in the areas of new synthetic drugs and Immunotherapies.
The company also offers spherical metal powders for additive manufacturing; and develops novel biomaterial for regenerative medicine.
ZIM Corporation was founded in 1997 and is headquartered in Ottawa, Canada.
ZIM Corporation
| Country | Canada |
| Founded | 1997 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 5 |
| CEO | Michael C. Cowpland |
Contact Details
Address: 150 Isabella Street Ottawa, ON K1S 1V7 Canada | |
| Website | zim.biz |
Stock Details
| Ticker Symbol | ZIMCF |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | CA9895552060 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael C. J. Cowpland | President, Chief Executive Officer and Director |
| John A. Chapman B.Tech., C.M.A., C.P.A., M.B.A., P.Eng. | Chief Financial Officer and Consultant |